IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques
Top Cited Papers
- 23 October 2002
- journal article
- Published by Elsevier in Brain Research
- Vol. 956 (2) , 202-210
- https://doi.org/10.1016/s0006-8993(02)03436-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Imaging Brain Amyloid of Alzheimer Disease in Vivo in Transgenic Mice with an Aβ Peptide RadiopharmaceuticalJournal of Cerebral Blood Flow & Metabolism, 2002
- Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brainJournal of Neurochemistry, 2001
- Imaging Alzheimer's amyloidNature Biotechnology, 2000
- Therapeutic approaches to Alzheimer’s diseaseCurrent Opinion in Chemical Biology, 2000
- Aβ1-40 Peptide Radiopharmaceuticals for Brain Amyloid Imaging: 111In Chelation, Conjugation to Poly(ethylene glycol)-Biotin Linkers, and Autoradiography with Alzheimer's Disease Brain SectionsBioconjugate Chemistry, 2000
- Synthesis and Amyloid Binding Properties of Rhenium Complexes: Preliminary Progress Toward a Reagent for SPECT Imaging of Alzheimer's Disease BrainJournal of Medicinal Chemistry, 1999
- The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's diseaseTrends in Cell Biology, 1998
- Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.Journal of Clinical Investigation, 1997
- Regulation of Tau Phosphorylation in Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 1996
- Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probeNeurobiology of Aging, 1995